2m 2m 2m 2m 2m 2m 2m
XILIO THERAP (XLO)
NASDAQ
$8.15$0.00 (0.00%)
Price as of Jun 03, 2026 6:42 PM EDT- $50.6MMarket Cap
- -13.34%1-Year Change
- BiotechnologyIndustry
XILIO THERAP (XLO)
$8.15$0.00 (0.00%)
XLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.14 | ||
Change | -$0.05 (-0.61%) | ||
Open | $8.29 | ||
High | $8.33 | ||
Low | $8.09 | ||
Previous Close | $8.20 | ||
Volume | 9,638 | ||
30-Day Average Volume | 63,014 | ||
1-Week Change | -1.80% | ||
1-Month Change | -1.44% | ||
1-Year Change | -13.34% | ||
3-Year Change | -80.35% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 6.0M | ||
Total Assets | $163.5M | ||
Market Cap | $50.6M | ||
Enterprise Value | -$99.7M | ||
Period: QTR TTM FY | |||
Revenue | $12.6M | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$22.9M | ||
EBIT | -$9.5M | ||
EBITDA | -$9.2M | ||
Net Working Capital | $111.2M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | 11 | ||
Enterprise Value/Revenue | -8 | ||
P/B | 1 | ||
P/E | -15 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 14 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue